PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer

American Journal of Pathology

Volumn 181, Issue 4, 2012, Pages 1443-1454

  Sampson, Natalie ^a,c   Ruiz, Christian ^b   Zenzmaier, Christoph ^a   Bubendorf, Lukas ^b   Berger, Peter ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CANCER TESTIS ANTIGEN; PROSTATE ASSOCIATED GENE 4 PROTEIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANDROGENS; ANILIDES; ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL NUCLEUS; DISEASE PROGRESSION; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIGANDS; MALE; MICE; NITRILES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN STABILITY; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TOSYL COMPOUNDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866499457     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.06.040     Document Type: Article

References (62)

1. N. Sampson, G. Untergasser, E. Plas, P. Berger The ageing male reproductive tract J Pathol 211 2007 206 218 (Pubitemid 46195519)
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. L.J. Denis, K. Griffiths Endocrine treatment in prostate cancer Semin Surg Oncol 18 2000 52 74 (Pubitemid 30036120)
4. E.M. Basch, M.R. Somerfield, T.M. Beer, M.A. Carducci, C.S. Higano, M.H. Hussain, H.I. Scher American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer J Clin Oncol 25 2007 5313 5318 (Pubitemid 350232264)
5. A. Molina, A. Belldegrun Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling J Urol 185 2011 787 794
6. C.D. Chen, D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, C.L. Sawyers Molecular determinants of resistance to antiandrogen therapy Nat Med 10 2004 33 39 (Pubitemid 38524696)
7. J.A. Ruizeveld de Winter, P.J. Janssen, H.M. Sleddens, M.C. Verleun-Mooijman, J. Trapman, A.O. Brinkmann, A.B. Santerse, F.H. Schroder, T.H. van der Kwast Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer Am J Pathol 144 1994 735 746 (Pubitemid 24172062)
8. K.R. Lamont, D.J. Tindall Minireview: alternative activation pathways for the androgen receptor in prostate cancer Mol Endocrinol 25 2011 897 907
9. H.V. Heemers, D.J. Tindall Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex Endocr Rev 28 2007 778 808 (Pubitemid 350294296)
10. I.M. Wolf, M.D. Heitzer, M. Grubisha, D.B. DeFranco Coactivators and nuclear receptor transactivation J Cell Biochem 104 2008 1580 1586
11. H.V. Heemers, L.J. Schmidt, Z. Sun, K.M. Regan, S.K. Anderson, K. Duncan, D. Wang, S. Liu, K.V. Ballman, D.J. Tindall Identification of a clinically relevant androgen-dependent gene signature in prostate cancer Cancer Res 71 2011 1978 1988
12. L. Jia, B.P. Berman, U. Jariwala, X. Yan, J.P. Cogan, A. Walters, T. Chen, G. Buchanan, B. Frenkel, G.A. Coetzee Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity PloS One 3 2008 e3645
13. C.E. Massie, B. Adryan, N.L. Barbosa-Morais, A.G. Lynch, M.G. Tran, D.E. Neal, I.G. Mills New androgen receptor genomic targets show an interaction with the ETS1 transcription factor EMBO Rep 8 2007 871 878 (Pubitemid 350001432)
14. Q. Wang, W. Li, X.S. Liu, J.S. Carroll, O.A. Janne, E.K. Keeton, A.M. Chinnaiyan, K.J. Pienta, M. Brown A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth Mol Cell 27 2007 380 392 (Pubitemid 47126935)
15. Q. Wang, W. Li, Y. Zhang, X. Yuan, K. Xu, J. Yu, Z. Chen, R. Beroukhim, H. Wang, M. Lupien, T. Wu, M.M. Regan, C.A. Meyer, J.S. Carroll, A.K. Manrai, O.A. Janne, S.P. Balk, R. Mehra, B. Han, A.M. Chinnaiyan, M.A. Rubin, L. True, M. Fiorentino, C. Fiore, M. Loda, P.W. Kantoff, X.S. Liu, M. Brown Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Cell 138 2009 245 256
16. C.E. Comstock, M.P. Revelo, C.R. Buncher, K.E. Knudsen Impact of differential cyclin D1 expression and localisation in prostate cancer Br J Cancer 96 2007 970 979 (Pubitemid 46452276)
17. N. Sampson, G. Untergasser, C. Lilg, L. Tadic, E. Plas, P. Berger GAGEC1, a cancer/testis associated antigen family member, is a target of TGF-beta1 in age-related prostatic disease Mech Ageing Dev 128 2007 64 66 (Pubitemid 46073061)
18. G. Untergasser, R. Gander, C. Lilg, G. Lepperdinger, E. Plas, P. Berger Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation Mech Ageing Dev 126 2005 59 69 (Pubitemid 40018478)
19. U. Brinkmann, G. Vasmatzis, B. Lee, N. Yerushalmi, M. Essand, I. Pastan PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus Proc Natl Acad Sci U S A 95 1998 10757 10762 (Pubitemid 28413141)
20. M.F. Gjerstorff, H.J. Ditzel An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members Tissue Antigens 71 2008 187 192 (Pubitemid 351197085)
21. E. Fratta, S. Coral, A. Covre, G. Parisi, F. Colizzi, R. Danielli, H.J. Marie Nicolay, L. Sigalotti, M. Maio The biology of cancer testis antigens: putative function, regulation and therapeutic potential Mol Oncol 5 2011 164 182
22. Y. Zeng, Y. He, F. Yang, S.M. Mooney, R.H. Getzenberg, J. Orban, P. Kulkarni The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein J Biol Chem 286 2011 13985 13994
23. M. Hellman, H. Tossavainen, P. Rappu, J. Heino, P. Permi Characterization of intrinsically disordered prostate associated gene (PAGE5) at single residue resolution by NMR spectroscopy PloS One 6 2011 e26633
24. J. Chen, J. Cheng, A.K. Dunker Intrinsically disordered proteins: analysis, prediction, simulation, and biology Pac Symp Biocomput 17 2012 67 69
25. A. Tantos, K.H. Han, P. Tompa Intrinsic disorder in cell signaling and gene transcription Mol Cell Endocrinol 348 2012 457 465
26. P. Berger, W. Panmoung, D. Khaschabi, B. Mayregger, G. Wick Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay Endocrinology 123 1988 2351 2359
27. N. Sampson, R. Koziel, C. Zenzmaier, L. Bubendorf, E. Plas, P. Jansen-Durr, P. Berger ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma Mol Endocrinol 25 2011 503 515
28. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
29. C. Zenzmaier, N. Sampson, D. Pernkopf, E. Plas, G. Untergasser, P. Berger Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia Endocrinology 151 2010 3975 3984
30. T. Zellweger, C. Ninck, M. Bloch, M. Mirlacher, P.A. Koivisto, H.J. Helin, M.J. Mihatsch, T.C. Gasser, L. Bubendorf Expression patterns of potential therapeutic targets in prostate cancer Int J Cancer 113 2005 619 628 (Pubitemid 40038739)
31. C. Ruiz, D.R. Holz, M. Oeggerli, S. Schneider, I.M. Gonzales, J.M. Kiefer, T. Zellweger, A. Bachmann, P.A. Koivisto, H.J. Helin, S. Mousses, M.T. Barrett, D.O. Azorsa, L. Bubendorf Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer J Pathol 223 2011 543 552
32. K. Prakash, G. Pirozzi, M. Elashoff, W. Munger, I. Waga, R. Dhir, Y. Kakehi, R.H. Getzenberg Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays Proc Natl Acad Sci U S A 99 2002 7598 7603 (Pubitemid 34568737)
33. L. Sheflin, B. Keegan, W. Zhang, S.W. Spaulding Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels Biochem Biophys Res Commun 276 2000 144 150
34. D. Gioeli, S.B. Ficarro, J.J. Kwiek, D. Aaronson, M. Hancock, A.D. Catling, F.M. White, R.E. Christian, R.E. Settlage, J. Shabanowitz, D.F. Hunt, M.J. Weber Androgen receptor phosphorylation Regulation and identification of the phosphorylation sites J Biol Chem 277 2002 29304 29314
35. H.K. Lin, Y.C. Hu, L. Yang, S. Altuwaijri, Y.T. Chen, H.Y. Kang, C. Chang Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers J Biol Chem 278 2003 50902 50907 (Pubitemid 38020321)
36. I. Palazzolo, B.G. Burnett, J.E. Young, P.L. Brenne, A.R. La Spada, K.H. Fischbeck, B.W. Howell, M. Pennuto Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity Hum Mol Genet 16 2007 1593 1603 (Pubitemid 47050673)
37. F.N. Hsu, M.C. Chen, M.C. Chiang, E. Lin, Y.T. Lee, P.H. Huang, G.S. Lee, H. Lin Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5 J Biol Chem 286 2011 33141 33149
38. V. Gordon, S. Bhadel, W. Wunderlich, J. Zhang, S.B. Ficarro, S.A. Mollah, J. Shabanowitz, D.F. Hunt, I. Xenarios, W.C. Hahn, M. Conaway, M.F. Carey, D. Gioeli CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation Mol Endocrinol 24 2010 2267 2280
39. S. Chen, S. Gulla, C. Cai, S.P. Balk Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation J Biol Chem 287 2012 8571 8583
40. Y. Wang, J.I. Kreisberg, P.M. Ghosh Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer Curr Cancer Drug Targets 7 2007 591 604 (Pubitemid 47358145)
41. M.L. Zhu, N. Kyprianou Androgen receptor and growth factor signaling cross-talk in prostate cancer cells Endocr Relat Cancer 15 2008 841 849
42. X. Liu, R.Y. Choi, S.M. Jawad, J.T. Arnold Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells Prostate 71 2011 766 777
43. P. McCall, L.K. Gemmell, R. Mukherjee, J.M. Bartlett, J. Edwards Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients Br J Cancer 98 2008 1094 1101 (Pubitemid 351399795)
44. B.E. Black, M.J. Vitto, D. Gioeli, A. Spencer, N. Afshar, M.R. Conaway, M.J. Weber, B.M. Paschal Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions Mol Endocrinol 18 2004 834 850 (Pubitemid 38429476)
45. S.S. Taneja, S. Ha, N.K. Swenson, H.Y. Huang, P. Lee, J. Melamed, E. Shapiro, M.J. Garabedian, S.K. Logan Cell-specific regulation of androgen receptor phosphorylation in vivo J Biol Chem 280 2005 40916 40924 (Pubitemid 41780585)
46. U.S. Shah, J. Arlotti, R. Dhir, S. Lu, G. Pirozzi, K. Prakash, R.H. Getzenberg Androgen regulation of JM-27 is associated with the diseased prostate J Androl 25 2004 618 624 (Pubitemid 38880196)
47. Y. Liu, Q. Zhu, N. Zhu Recent duplication and positive selection of the GAGE gene family Genetica 133 2008 31 35 (Pubitemid 351464221)
48. H.K. Lin, Y.C. Hu, D.K. Lee, C. Chang Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells Mol Endocrinol 18 2004 2409 2423 (Pubitemid 39335977)
49. N. Schrantz, J. da Silva Correia, B. Fowler, Q. Ge, Z. Sun, G.M. Bokoch Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling J Biol Chem 279 2004 1922 1931 (Pubitemid 38084463)
50. Y. Zhang, Y. Yang, S. Yeh, C. Chang ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation Mol Cell Biol 24 2004 1044 1057 (Pubitemid 38112169)
51. M.R. Cardillo, E. Petrangeli, L. Perracchio, L. Salvatori, L. Ravenna, F. Di Silverio Transforming growth factor-beta expression in prostate neoplasia Anal Quant Cytol Histol 22 2000 1 10 (Pubitemid 30106500)
52. W.G. Nelson, A.M. De Marzo, S. Yegnasubramanian Epigenetic alterations in human prostate cancers Endocrinology 150 2009 3991 4002
53. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, J.H. Luo Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790 2799 (Pubitemid 41079896)
54. E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, W.L. Gerald Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res 62 2002 4499 4506 (Pubitemid 34827314)
55. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, W.R. Sellers Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209 (Pubitemid 41039166)
56. T. Suyama, T. Shiraishi, Y. Zeng, W. Yu, N. Parekh, R.L. Vessella, J. Luo, R.H. Getzenberg, P. Kulkarni Expression of cancer/testis antigens in prostate cancer is associated with disease progression Prostate 70 2010 1778 1787
57. T. Shiraishi, N. Terada, Y. Zeng, T. Suyama, J. Luo, B. Trock, P. Kulkarni, R.H. Getzenberg Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy J Transl Med 9 2011 153
58. Y. Niu, S. Altuwaijri, K.P. Lai, C.T. Wu, W.A. Ricke, E.M. Messing, J. Yao, S. Yeh, C. Chang Androgen receptor is a tumor suppressor and proliferator in prostate cancer Proc Natl Acad Sci U S A 105 2008 12182 12187
59. S. Memarzadeh, H. Cai, D.M. Janzen, L. Xin, R. Lukacs, M. Riedinger, Y. Zong, K. DeGendt, G. Verhoeven, J. Huang, O.N. Witte Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal Proc Natl Acad Sci U S A 108 2011 7962 7967
60. R. Chmelar, G. Buchanan, E.F. Need, W. Tilley, N.M. Greenberg Androgen receptor coregulators and their involvement in the development and progression of prostate cancer Int J Cancer 120 2007 719 733 (Pubitemid 46175390)
61. P.J. Hendriksen, N.F. Dits, K. Kokame, A. Veldhoven, W.M. van Weerden, C.H. Bangma, J. Trapman, G. Jenster Evolution of the androgen receptor pathway during progression of prostate cancer Cancer Res 66 2006 5012 5020 (Pubitemid 43844921)
62. H. Bonkhoff, R. Berges From pathogenesis to prevention of castration resistant prostate cancer Prostate 70 2010 100 112